Browse by author
Lookup NU author(s): Dr Paul Mackin, Professor Allan Young
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
There is robust evidence demonstrating abnormalities of the HPA axis in bipolar disorder. Hypercortisolism may be central to the pathogenesis of depressive symptoms and cognitive deficits, which may in turn result from neurocytotoxic effects of raised cortisol levels. Manic episodes may be preceded by increased ACTH and cortisol levels, leading to cognitive problems and functional impairments. Identification and effective treatment of mood and cognitive symptoms of mood disorders are clinical goals, but currently available treatments may fall short of this ideal. Manipulation of the HPA axis has been shown to have therapeutic effects in preclinical and clinical studies, and recent data suggest that direct antagonism of GRs may be a future therapeutic strategy in the treatment of mood disorders. © 2005 Elsevier Inc. All rights reserved.
Author(s): Daban C, Vieta E, Mackin P, Young AH
Publication type: Review
Publication status: Published
Journal: Psychiatric Clinics of North America
Year: 2005
Volume: 28
Issue: 2
Pages: 469-480
Print publication date: 01/04/2005
ISSN (print): 0193-953X
ISSN (electronic): 1558-3147
URL: http://dx.doi.org/10.1016/j.psc.2005.01.005
DOI: 10.1016/j.psc.2005.01.005
PubMed id: 15826743
